Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00571064 · ClinicalTrials.gov registry record · Phase 4
The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility
A Phase 4 study, sponsored by Eisai.
- Completed
- Registry status
- Phase 4
- Development phase
- 97
- Enrollment target
NCT00571064 is a Phase 4 study that has completed, run by Eisai. The registered enrollment target is 97 participants.
The verdict
NCT00571064, a Phase 4 study, has completed, sponsored by Eisai.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 97 participants
- Enrollment target
Study Summary
This is a study to determine the effectiveness and safety of donepezil hydrochloride (E2020) used to treat residents of assisted living facilities diagnosed with mild, moderate, or severe stage Alzheimer's disease.
Interventions
- DRUG Donepezil HCl
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97 participants |
| Start Date | 2008-01 |
| Est. Completion | 2009-04-22 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00571064
The ClinicalTrials.gov registry entry for NCT00571064 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 97 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eisai, which has 287 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Donepezil HCl is the first listed.
NCT00571064 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00571064 about?
NCT00571064 is a clinical study titled "The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility". This is a study to determine the effectiveness and safety of donepezil hydrochloride (E2020) used to treat residents of assisted living facilities diagnosed with mild, moderate, or severe stage Alzheimer's disease.
What is the current status of trial NCT00571064?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 97 participants. The study started on 2008-01. Estimated completion is 2009-04-22.
What interventions are being tested in trial NCT00571064?
The interventions under investigation include: Donepezil HCl (DRUG).
Who is sponsoring clinical trial NCT00571064?
This trial is sponsored by Eisai, which has 287 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.